Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
Journal of Pathology Informatics|January 13, 2025
A standards-based application for improving platelet transfusion workflowWilliam Gordon, Maria Aguad, Layne Ainsworth, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Transplantation and Cellular Therapy|June 13, 2025
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy: Consensus Response Criteria for TA-TMAMichelle L Schoettler, Eleni Gavriilaki, Enric Carreras, et al.
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortalityMargaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
Journal of Pathology Informatics|January 13, 2025
A standards-based application for improving platelet transfusion workflowWilliam Gordon, Maria Aguad, Layne Ainsworth, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Transplantation and Cellular Therapy|June 13, 2025
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy: Consensus Response Criteria for TA-TMAMichelle L Schoettler, Eleni Gavriilaki, Enric Carreras, et al.
Transplantation and Cellular Therapy|April 4, 2023
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationJuliana Vergara-Cadavid, P Connor Johnson, Haesook T Kim, et al.
Blood Advances|May 15, 2024
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survivalRoman M Shapiro, Haesook T Kim, Remy Dulery, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortalityMargaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Pageof 23